Benjamin T. Dake

Ben Dake is the President of Aerovate Therapeutics, where Ben serves as the Founding CEO. Prior to this, Ben worked as an Investor at RA Capital Management and as the Co-Founder of Gallup G Team. Ben holds a PhD in Cell, Molecular and Developmental Biology from Tufts University School of Medicine, a Master of Science in Virology from the University of Nebraska-Lincoln, and a Bachelor of Science in Biological and Physical Sciences from the same university.